The primary objective of this study was to classify patients with CAD as regards their gluco-metabolic state by easily available clinical variables. A secondary objective was to explore if it was possible to identify CAD patients at a high cardiovascular risk due to metabolic perturbations. The 1,867 patients with CAD were gluco-metabolically classified by an OGTT. Among these, 990 patients had complete data regarding all components of the metabolic syndrome, BMI, HbA1c and medical history. Only FPG and HDL-c adjusting for age significantly impacted OGTT classification. Based on these variables, a neural network reached a cross-validated misclassification rate of 37.8% compared with OGTT. By this criterion, 1,283 patients with complete one-year follow-up concerning all-cause mortality, myocardial infarction and stroke (CVE) were divided into low-and high-risk groups within which CVE were, respectively, 5.1 and 9.4% (p=0.016). Adjusting for confounding variables the relative risk for a CVE based on the neural network was 2.06 (95% CI: 1.18-3.58) compared with 1.37 (95% CI: 0.79-2.36) for OGTT. Conclusions: The neural network, based on FPG, HDL-c and age, showed useful risk stratification capacities; it may, therefore, be of help when stratifying further risk of CVE in CAD patients.
Introduction
A combination of well-established risk factors for cardiovascular disease, including disturbed glucose metabolism, dyslipidaemia, hypertension and obesity has been clustered in the so called 'metabolic syndrome'. 1 The cardiovascular risk associated with this syndrome seems to be greater than the risk associated with its individual components. The metabolic syndrome has indeed been referred to as an independent predictor of mortality in patients with CAD. 2, 3 On the other hand, screening for glucose abnormalities is strongly recommended in all patients with CAD. 4 An OGTT discloses that as many as two-thirds of such patients, without previously known gluco-metabolic perturbations, have impaired glucose regulation or diabetes. 5 Importantly, these conditions are independent predictors of adverse outcomes in CAD patients. 6, 7 In accordance with these principles, a combination of metabolic abnormalities further enhances the risk for subsequent cardiovascular events as mortality, new infarctions and stroke. Risk prediction then becomes important and simple tools are needed, preferably applicable as soon as possible following diagnosis.
A relatively new computational tool, 8 ANN, has been extensively used to address complex real-world problems, particularly when dealing with non-linear models or when the underlying mechanisms are incompletely defined. ANN may represent a valid support owing to its ability to find patterns in data involving many variables.
The primary objective of this study was to classify patients with CAD with regard to their gluco-metabolic state by incorporating commonly available clinical variables in statistical learning models. A secondary objective was to explore whether it might be possible, at an early stage, to identify CAD patients at a high cardiovascular risk due to metabolic perturbations linked to dysglycaemia.
Methods
The Euro Heart Survey on Diabetes and the Heart recruited consecutive patients above the age of 18 years, with a diagnosis of CAD when acutely or electively admitted to hospital wards or outpatient clinics in 110 centres in 25 countries. Patients were assessed, investigated and treated at the discretion of their responsible physicians according to usual institutional practice.
A detailed description of the survey has been presented elsewhere. 5 Data demography, anthropometric measures, conventional risk factors, medical history and test results were collected for each patient by means of a web-based electronic case record form.
National requirements for ethical approval were adhered to.
Patients were followed-up with respect to CVE (all-cause mortality, myocardial infarction or stroke), cardiovascular procedures (PCI and CABG) and treatment for at least one year.
Gluco-metabolic parameters
The investigators were asked to provide measurement of fasting plasma glucose (FPG) in every patient at enrolment or in the morning of the day following hospital admission. The protocol recommended that all patients without prevously diagnosed diabetes should undergo a standard OGTT according to WHO recommendations (75 g glucose in 200-250 ml water) in a stable condition prior to hospital discharge or within two months following index consultation. Glucose concentrations were measured according to local routines if possible in venous plasma. Glucose concentrations derived from different types of samples (capillary plasma or capillary whole blood) were converted to venous plasma glucose, expressed in mmol/L by means of conversion factors outlined by the European Diabetes Epidemiology Group working at the DECODE study. 9 Based on the outcome of the OGTT, patients were allocated into the following categories according to WHO 10 (Table 1) : NGR, IFG, IGT or T2DM. In the following, IGR comprises IFG and IGT.
Supported by published data on the survey concerning adverse outcomes 6 patients with T2DM were defined as high-risk patients compared with those with IGR or NGR, which were defined as low-risk.
Statistical methods
Descriptive statistics were produced using STATISTICA (v 7.1, StatSoft Inc.). Continuous variables were expressed as median and quartiles and categorical variables as counts and/or proportions. Weighted kappa (κ) 11 , the chance corrected proportional agreement, was used to measure the degree of coherence between gluco-metabolic classification based on the OGTT ('gold standard') and the other algorithms.
Classification was performed by means of OLR (Minitab® release 13.32) and a single hidden layer feed-forward ANN (Matlab® release 14.0). To avoid the observations being classified influencing the model fit 10-fold cross-validation was used for all classifications. Cross-validation was also used to estimate the standard error (SE) of the parameter estimates.
The following continuous variables, based on the NCEP 12 definition of the metabolic syndrome, were considered candidates: FPG, HDL-c, triglycerides, systolic and diastolic blood pressure, and waist circumference. In addition BMI, HbA1c and dichotomous variables regarding previous myocardial infarction, stroke, hypertension and family history of diabetes were considered candidate input variables, adjusting for age and sex when needed. Details concerning the cross-validation, OLR and ANN models applied are reported in the Appendix.
Kaplan-Meier curves were computed for CVE and the log-rank test was used for comparing groups. Multiple Cox proportional hazard regression (SAS v. 9.1 PROC PHREG) was used to analyse the relation between risk criteria based on the gluco-metabolic classification and one-year outcome, alone and after adjusting for confounding variables. These variables were selected among age, sex, clinical status (acute or elective), previous medical history (myocardial infarction, heart failure, peripherial artery disease, CABG or PCI), hypertension, hyperlipidaemia, baseline characteristics (triglycerides, diastolic and systolic blood pressure, waist circumference), smoking habits, interventions (CABG or PCI) and medications (beta blockers, renin-angiotensin-aldosteron system blockers, oral antiaggregants and statins) during follow-up. The best subset approach, using Akaike information criterion (AIC) as performance measure, was used to find an optimal set of significant confounders and also to compare the predictive ability of the different risk indices in adjusted models. The AIC is minus two times the log likelihood plus a penalty function of two times the number of predictors in the model; the smaller the value of this criterion the better the model. The rationale behind this criterion is that if the only difference between two models is that a chance predictor has been included, the values of AIC for the two models will not differ much, if anything AIC will tend to increase including the chance variable. Moreover the AIC is an approximate measure of the prediction accuracy. The penalty function accounts for the fact that the same data are being used to fit the model and assess it through the likelihood. The assumption of proportional hazards was assessed by visual inspection of the log-log survival curves for the categorical variables. Continuous variables were categorised and a graphical approach was applied to verify the linearity assum ption. Results are reported as HRs and 95% CI. A two-sided p-value <0.05 was considered statistically significant.
Generalisation of the neural network
To determine reproducibility, the resulting ANN model was applied on the GAMI study population comprising 172 patients. 13 These patients were followed regarding cardiovascular mortality, myocardial infarction and stroke for a median time of 2.8 (2.3-3.3) years.
Results
Of the 3,362 patients with unknown gluco-metabolic status recruited in the survey, an OGTT was performed in 1867 (56%), 909 (64%) and 958 (49%), respectively, among the acutely and electively admitted groups. Patients in whom an OGTT was not performed (n=1,495) were older (67, 58-75 vs. 64, 55-72), more frequently females (29 vs. 24%), had a higher prevalence of known heart failure (21 vs. 15%) and more frequently a history of myocardial infarction (45 vs. 41%) than those undergoing this test. The classification of glucose metabolism based on OGTT can be seen in Table 1 .
OLR
Complete information on all candidate variables for the ordinal regression analysis was available in 990 (53%) of the 1867 patients that underwent an OGTT, 555 (56%) and 435 (44%) of the acutely and electively admitted patients, respectively. Besides gender and age (males 79% vs. 72% and lower median age 62.7 vs. 65 among those with all candidate predictors), baseline characteristics were comparable between patients with and without complete available information. The distribution on gluco-metabolic classes did not differ between these two groups of patients (data not shown). Table 2 summarises clinical and laboratory characteristics of patients presenting all candidate variables stratified by gluco-metabolic state. The only variables with a significant impact (p<0.05) on the OGTT classification criterion were FPG, HDL-c and age. The best identification of subjects with NGR, IGR and T2DM applying OLR was achieved by the following algorithm (SE, based on crossvalidation, within brackets): As reported in details elsewhere, 14 a patient was classified (Table 3 , upper part) according to the value of the algorithm, presented within brackets, as having NGR (<-2.17), IGR (-2.17-0.0) or T2DM (>0). The OLR classification algorithm reached a cross-validated misclassification rate of 44.8%, weighted κ=0.45 (95% CI 0.40-0.50). The odds of having either IGR or T2DM increased by 3.78 (95% CI 3.16-4.51) for each mmol/L increase in FPG and by 1.04 (95% CI 1.02-1.05) for every year of age. The odds 
Neural network modelling
The ANN was designed as a single hidden layer feedforward network (Figure 1 ). The final model included FPG (mmol/L), HDL-c (mmol/L), and age (years). Details concerning the estimates of the parameters in the hidden layer and the probability that a patient belonged to a specific gluco-metabolic category are reported in the Appendix. Patients were classified into the gluco-metabolic category for which their estimated probability was largest. As presented in Table 3 (lower part), the ANN classification algorithm reached a cross-validated misclassification rate of 37.9%, weighted κ=0.49 (95% CI 0.44-0.54).
Cardiovascular prognosis
The one-year CVE incidence in the 1,283 patients with complete data regarding FPG, HDL-c and age is reported in Table 4 . The three classification criteria, OGTT, OLR and ANN, produced different distributions of the one-year events within the different classes. Only the ANN criterion reported proportions of one-year CVE that differed significantly between the gluco-metabolic classes (p=0.044). Cox regression models comparing patients at high risk (T2DM) with those at low risk (NGR or IGR) based on the different classification criteria, showed a better capability of the ANN, both in unadjusted and adjusted models, in predicting one-year CVE (Table 4) .
Kaplan-Meier curves for survival free from myocardial infarction and stroke in patients characterised as being low or high-risk patients by the ANN criterion are shown in Figure 2a . Corresponding Kaplan-Meier curves for survival free from myocardial infarction and stroke in patients characterised by OGTT are presented in Lenzen et al. 6 
Generalisation of the neural network
To test reproducibility, the resulting ANN was applied to another patient population derived from the GAMI study. They were gluco-metabolically classified by means of an OGTT and the follow-up time was longer (median 2.8 years).
Baseline characteristics of these patients (n=172) are described in detail elsewhere. 13 Cox regression model comparing GAMI patients at high risk with those at low risk showed an HR for cardiovascular mortality, myocardial infarction and stroke of 1.8 (95% CI 0.9-3.5). Kaplan-Meier curves for these events among patients characterised as being low-or high-risk patients by the ANN criterion are shown in Figure 2b .
Discussion
The single hidden layer feed-forward ANN presented a higher performance both before and after adjustment (HR 1.88 and 2.06) compared with the logistic regression model (HR 1.51 and 1.33) and the OGTT (HR 1.69 and 1.37) in detecting one-year, event-free survival. The feasibility to generalisation of these results -the ANN was already generalised to a larger population than the training set in Table 2 -was confirmed when applied on another population of patients with coronary artery disease manifestations.
Reasonably the small population size of the latter explained the lack of formal statistical significance, but the risk prediction trend was obvious. This suggests that an ANN prognostic criterion based on a few easily available clinical variables may be a useful tool for risk stratification of patients with CAD. The identification of individuals at increased risk for CVE is the critical first step towards reducing subsequent cardiovascular morbidity and mortality. Both high-and low-risk patients will benefit the former by being identified as candidates for a multifactorial management strategy, and the latter by avoiding complications and added expense from unnecessary medications and procedures. 15 The best possible risk prediction is a prerequisite for an individualised medical approach, and appropriate statistical models for risk stratification are promising tools.
Besides FPG, definitely crucial for any algorithm, a number of well-established risk factors for cardiovascular disease including dyslipidaemia, hypertension and obesity have been clustered into the metabolic syndrome. 1 A seven-year cardiovascular risk associated with this syndrome was superior to the risk associated with its individual components in a study comprising about 3,550 patients 16 and proved a strong independent predictor of mortality in patients with CAD.
2 That all components of the metabolic syndrome may play a relevant role 17 is supported by the success of multifactorial management strategies in reducing micro-and macrovascular complications in patients with T2DM. 18, 19 Of the single components, gluco-metabolic state and HDL-c recently proved to predict cardiovascular mortality with equal or higher HRs than the combination of all components of the syndrome, raising concerns about the importance of including the full cluster in risk prediction models. 20 The present gluco-metabolic risk index simplifies the approach by limiting needed variables to FPG, HDL-c and age, all quickly and easily available. As well as being the only 'cholesterol' considered in the NCEP definition of the metabolic syndrome, HDL-c has been given a central role as a cardiovascular marker for its multiple endothelial and anti-thrombotic actions. 21 The importance of HDL-c levels in predicting cardiovascular follow-up in patients with diabetes has been discussed, 22 and HDL-c has indeed been defined as a 'guardian angel' of the arterial walls. 23 Moreover the vast use of statins in patients with cardiovascular disease influences total and LDL-c while HDL-c, less influenced by such treatment, acts as a more reliable risk marker.
Gluco-metabolic perturbations have an independent negative influence on the prognosis in patients with CAD. In 168 patients without previously known DM, the probability of remaining free from cardiovascular events (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke or severe heart failure) following a myocardial infarction was significantly higher in patients with normal than newly detected abnormal glucose tolerance (p=0.002). Together with previous myocardial infarction, abnormal glucose tolerance was the strongest predictor of future cardiovascular events (HR 4.18; 95% CI 1.26-13.84; p=0.019).
7 Furthermore in 4676 patients followed with respect to cardiovascular events in the Euro Heart Survey on Diabetes and the Heart previously recognised and newly detected DM were associated with an increased risk of one-year mortality when compared with the prognosis among patients with normal glucose regulation (HR 2.4, 95% CI 1.5-3.8 and HR 2.0, 95% CI 1.1-3.6, respectively). 6 When unknown, an OGTT represents the gold standard for gluco-metabolic assessment. 4 , 10 A statistical model can hardly be superior to the direct in vivo metabolic response to a glucose load. In fact, misclassification rates of both the OLR and ANN models proved not satisfactory (45% and 38%, respectively, compared with OGTT). However, due to the prevailing difficulties in achieving OGTTs in all-day clinical practice -confirmed by the fact that only 56% of the survey population requiring an OGTT actually underwent this test -other methods predicting cardiovascular prognosis need to be investigated.
Neural network model
When applying an ANN, besides the selection of the data, the decision of an appropriate and efficient training algorithm is of great importance. 24 Literature support to the methods used in the present work is discussed in the Appendix.
The ANN improved the gluco-metabolic classification decreasing error rate from 45% to 38% (Table 3) . Using FPG, HDL-c and age as input variables, this model may be a helpful tool for gluco-metabolic classification in case of OGTT unavailability, and more interestingly, for direct cardiovascular risk stratification.
There are opinions ranging from enthusiasm to scepticism on the usefulness of ANNs in human medical studies 25 and many comparisons have been assessed with other approaches.
Comparing ANNs to traditional logistic regression models in predicting five-year survival after colon carcinoma treatment 26 or pathological stage of prostate cancer 27 showed superiority of the former. Comparison with expert opinions in diagnosis and the prediction of survival in colon cancer, 28 breast cancer diagnosis, 29 and in the evaluation of activity in pulmonary tuberculosis lesions, 30 also revealed a higher performance and accuracy of the ANNs. On the other hand, human experts are generally of inferior accuracy also when compared with predictions made by classical statistical models 31 and studies in which an ANN showed lower performance compared with classical Bayesian methods have been presented. 32 Few methodology reviews 33, 34 have been performed on this issue summarising differences and similarities of the different models from a technical point. The overall feeling is that a correctly constructed ANN, 35 providing a possibility for an unlimited number of linear or non-linear boundaries, has a higher flexibility than classical statistical methods. However, both methods still need to be used and explored in a complementary manner.
Strengths and limitations related to the survey structure
Surveys within the framework of the European Society of Cardiology, recruiting patients as part of all-day services, are intended to more truly reflect clinical practice than trials that by necessity are restricted to patients included according to a study protocol. The current survey is based on almost 5000 individuals with a wide range of acute or stable CAD. Although the survey involved centres and investigators sensible to the argument, an OGTT was performed in only slightly more than half of the eligible patients. The reasons were that some countries refused ethical permission to perform an OGTT together with technical obstacles related to arrangement of the test. For the outcome of the present evaluation this lack of tests should not be a major concern. Considering available clinical characteristics, it is unlikely that the diagnostic accuracy would have been different in patients not tested.
Conclusion
The single hidden layer feed-forward ANN criterion, based on FPG, HDL-c and age, easy to implement in any personal digital assistant or computer, showed useful risk stratification capacities. It could be of great clinical importance for identifying patients at high risk of future cardiovascular events, directing physicians towards those high-risk patients that would gain from a more aggressive management.
cross-validation is leave-one-out, omitting one observation at a time, while the others are used for model fitting. The omitted observation is then classified. This avoids the observation being classified to influence the model fit. It has been argued that leave-one-out perturbs the sample too little making the estimates too variable if they do not depend smoothly on the empirical distribution. 36 This and other problems can be avoided by leaving out groups of observations rather than a single observation. In general a data-set can be split into K roughly equal-sized groups either at random or balanced with respect to the number of observations in each classification category (K-fold cross-validation). In this study we chose to set K equal to 10, which has been suggested as a good compromise. 37 An OLR assuming proportional odds was applied for the three gluco-metabolic classes (NGR, IGR and T2DM) on the subset of the study population (n=990) with complete candidate variables data. The best subset approach applying 10-fold cross-validation was used to detect the optimal set of classification variables. The models were compared with respect to the cross-validated misclassification rate.
The Neural Network Toolbox in Matlab® applying the resilient back-propagation optimisation algorithm was used to construct the single hidden layer feed-forward ANN. To limit the computational burden, the training of the ANN was based only on those variables with p-value < 0.2 in the simple OLR. The minimum number of variables in the hidden layer was two and the maximum two more than the number of input variables. Starting values for regression coefficients and intercepts where drawn from a uniform distribution on (-0.7, 0.7), i.e. all starting values were close to zero making the model start nearly linear. To avoid overfitting and improve generalisation of the results parameter decay was applied according to Mitchell et al. 38 using 10 tuning values (ranging from -∞ to -0.1, logarithmic scale). Parameter decay is analogous to ridge regression for linear models. Since the parameters are scale dependent the input variables were standardised.
Fifteen random starting configurations were used to avoid getting stuck in local minima since a penalised error function is often non-convex making the solution dependent on the starting configuration. The models were compared with respect to the cross-validated misclassification rate under the condition that at least half of the parameter estimates had a SNR >1. SNR was defined as the parameter estimate divided by its SEs. The same 15 starting configurations were used for each of the training set in the cross-validation. The final model was pruned including only parameter estimates with SNR >1 and the parameter estimates were transformed back to their original scales. A permutation test was used to assess the significance of the final model. 39 The estimates of the parameters in the hidden layer of the final model including age, FPG and HDL-c (SE, based on crossvalidation, within brackets) were: The final estimates of the probability (Prob) that a patient belonged to a specific glucose category (SE, based on crossvalidation, in superscript within brackets) were: A patient was classified into the glucose category for which his predicted probability was largest, e.g. into the T2DM category if Prob(T2DM) > max [Prob(IGR), Prob (NGR)]. The identification of the best technique for prediction of classification accuracy is a complex task and future research should compare different approaches, including unsupervised methods, 37 Previous literature suggests that, in case of small expression data-sets, the cross-validation and bootstraps methods provide the most conservative estimates, and could also be used for estimating standard errors of the parameter estimates, limiting the vision of the ANN as a 'black box'. 40 
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